MedPath

Evaluating 5ASA efficacy in treatment of symptomatic hemorrhoid

Phase 2
Recruiting
Conditions
hemorrhoids.
Unspecified haemorrhoids without complication
I84.9
Registration Number
IRCT20191226045897N2
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Sigmoidoscopy
Hemorrhoids based on clinical indicators and examination

Exclusion Criteria

Hemorrhoids stage 3 and up
Ulcerative proctitis
Pregnancy or breastfeeding
Allergy to salicylates
Liver dysfunction
Renal dysfunction

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Pain. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Anal burning. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath